| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Cash | 905 | |||
| Total current assets | 905 | |||
| Total assets | 905 | |||
| Accrued board of directors compensation | 317,249 | |||
| Accounts payable and accrued expenses | 10,466 | |||
| Due to related parties | 57,213 | |||
| Total current liabilities | 384,928 | |||
| Total liabilities | 384,928 | |||
| Accumulated deficit | -162,177,597 | |||
| Common stock - 0.001 par 900,000,000 shares authorized, 33,521,755 and 29,271,755 issued and outstanding, respectively | 33,522 | |||
| Additional paid-in-capital | 161,760,052 | |||
| Total stockholders deficit | -384,023 | |||
| Total liabilities and stockholders deficit | 905 | |||
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)